Feedback / Questions
CTM-N2D - CytoMed Therap
https://www.globenewswire.com/news-release/2025/07/21/3118840/0/en/Update-On-Clinical-Trial-Milestone-CytoMed-Therapeutics-Achieves-Completion-of-Dose-Level-1-of-its-ANGELICA-TRIAL-and-Proceeding-to-Dose-Level-2-in-Patients-with-Advanced-Solid-Tum.html
Jul 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next